Responses
Regular and young investigator award abstracts
Combination immunotherapies
453 Novel combination immunotherapy for boosting and priming immune responses in pancreatic cancer: strong anti-tumour effects with interleukin-15 and CD40 agonist treatment
Compose a Response to This Article
Other responses
No responses have been published for this article.